Connected With Latham
Durata totale:
19 h 14 min
Episode 115 – Drug Pricing and Market Access: Highlights From Recent CMS and AHLA Conferences
Connected With Latham
20:27
Episode 114 – The Growth Rocketship: Using AI and Human Expertise to Build Tomorrow's Leading Brands With A-Frame
Connected With Latham
56:15
Episode 113 – Helping Holocaust Survivors
Connected With Latham
39:16
Episode 112 – The Growth Rocketship: Navigating the Institutional Evolution of the Blockchain World With ParaFi
Connected With Latham
49:06
Episode 111 – The Growth Rocketship: The Future of Rewards-Based Advertising With Fetch
Connected With Latham
48:51
Episode 110 – Spotlight on US State Healthcare Transaction Review Laws
Connected With Latham
16:11
Episode 109 – Drug Pricing and Market Access: Key Takeaways From 2025 and Outlook for 2026
Connected With Latham
33:51
Episode 108 – UK FinReg Focus Areas in 2026
Connected With Latham
28:00
Episode 107 – Drug Pricing and Market Access: "Think of It as a Loop" — Succeeding in an Evolving Policy Landscape
Connected With Latham
22:07
Episode 106 – The FDA's New Playbook: Biosimilars, National Priority Vouchers, and the Plausible Mechanism Pathway
Connected With Latham
34:52
Episode 105 – Drug Pricing and Market Access: Government Pricing Assessment Expectations and Benefits
Connected With Latham
32:23
Episode 104 – Drug Pricing and Market Access: Deep Dive on the FDA Commissioner's National Priority Voucher Program Awards
Connected With Latham
36:56
Episode 103 – Drug Pricing: Takeaways from the Chicago Medicaid Drug Rebate Program Summit
Connected With Latham
19:53
Episode 102 – EU Data Act: Spotlight on Switching Requirements for Data Processing Services
Connected With Latham
21:26
Episode 101 – EU Data Act: Implications for Data Privacy and Cybersecurity
Connected With Latham
30:02
Episode 100 – The Leeds Reforms: Implications for UK Financial Services
Connected With Latham
21:33
Episode 99 – Drug Pricing: Takeaways from the Philadelphia Pricing and Contracting USA Conference
Connected With Latham
22:56
Episode 98 – Drug Pricing: Takeaways from the MDMA Annual Meeting
Connected With Latham
40:21
Episode 97 – Drug Pricing: How the Drug Pricing EO Impacts FDA and Overlaps with Grassley-Led Legislation
Connected With Latham
50:18
Episode 96 – The Growth Rocketship: Shield AI's Takeoff Shows What's Possible in Defensetech
Connected With Latham
52:23
Episode 95 – Drug Pricing: FDA in the Age of Executive Orders and DOGE
Connected With Latham
22:14
Episode 94 – Drug Pricing: 2025 J.P. Morgan Healthcare Conference Takeaways and Outlook
Connected With Latham
22:13
Episode 93 – EU's Digital Operational Resilience Act: What You Should Know and How to Stay Compliant
Connected With Latham
19:34
Episode 92 – UK FinReg Focus Areas in 2025: Sectoral Trends
Connected With Latham
29:45
Episode 91 – UK FinReg Focus Areas in 2025: Retail Markets
Connected With Latham
20:32
Episode 90 – UK FinReg Focus Areas in 2025: Wholesale Markets
Connected With Latham
23:23
Episode 89 – The Growth Rocketship: How BridgeBio's Hub and Spoke Portfolio Strategy Set the Market for the Future of Biotech – Then, Now, and What's Next?
Connected With Latham
47:21
Episode 88 – Drug Pricing: How Might the Trump Administration Transform FDA Enforcement Activities?
Connected With Latham
33:12
Episode 87 – Drug Pricing: What's In the New CMS Medicaid Final Rule?
Connected With Latham
28:38
Episode 86 – Drug Pricing: Takeaways from the Chicago Medicaid Drug Rebate Program Summit
Connected With Latham
18:25
Episode 85 – Drug Pricing: How The Demise of Chevron Deference and Other Litigation May Impact the Pharmaceutical Industry
Connected With Latham
21:48
Episode 84 – Pro Bono: Shabir Kabiri's Remarkable Journey from Afghanistan to Asylum in the US
Connected With Latham
34:22
Episode 83 – Drug Pricing: How Are Payers Responding to the IRA?
Connected With Latham
29:16
Episode 82 – Drug Pricing: Takeaways from the New Orleans Pricing and Contracting USA Conference
Connected With Latham
17:31
Episode 81 – Drug Pricing: A Look Behind the Curtain of the New ASP Reporting Website and Other Data Collection Portals
Connected With Latham
23:35
Episode 80 – Energy & Infrastructure: Why is Energy Tech So Attractive to Venture Capital?
Connected With Latham
26:13
Episode 79 – Pro Bono: Rewilding the Scottish Highlands Through Forest Restoration
Connected With Latham
16:03
Episode 78 – UK FinReg Focus Areas in 2024: ESG
Connected With Latham
17:12
Episode 77 – UK FinReg Focus Areas in 2024: Enforcement Against Individuals
Connected With Latham
08:23
Episode 76 – UK FinReg Focus Areas in 2024: Regulatory Divergence
Connected With Latham
17:49
